Clinical Trial Update: Safety Study to Evaluate the Contact Sensitizing Potential of Topically Applied ZuraPrep™ and ZuraPrep™ Without IPA [Phase 1]

View source ↗

Summary

Phase 1 safety trial assessing the potential for skin sensitization from topically applied ZuraPrep products, with and without IPA, in the context of surgical s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Surgical Site Infection

Drugs mentioned

• ZuraPrep
• ZuraPrep Without IPA

Snippet

Sponsor: Zurex Pharma, Inc. | Conditions: Surgical Site Infection | Phase 1 | Status: COMPLETED